To evaluate the reproducibility of the observation that glucocorticoid replacement in PAI was associated with a reduction in circulating GDF15 we assessed 2 independent PAI cohorts comprising of patients with Addison’s disease (cohort 2) or classical CAH (cohort 3). The gene discussed is GDF15; the disease is congenital adrenal hyperplasia.